Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence

BACKGROUND: Antithrombotic medications (anticoagulants and antiplatelets) are often withheld in the periprocedural period and after bleeding complications to limit the risk of new or recurrent bleeding. These medications are also stopped by patients for various reasons such as cost, side effects, or...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Broderick, Joseph P., Bonomo, Jordan B., Kissela, Brett M., Khoury, Jane C., Moomaw, Charles J., Alwell, Kathleen, Woo, Daniel, Flaherty, Matthew L., Khatri, Pooja, Adeoye, Opeolu, Ferioli, Simona, Kleindorfer, Dawn O.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166233/
https://ncbi.nlm.nih.gov/pubmed/21719769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.110.611905
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars